患有炎症性肠道疾病的青少年的远程监测:系统性审查
Mike P T Kusters1, Marleen Bouhuys2,3, Robin W M Vernooij1,4
1Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
European journal of pediatrics
|August 5, 2025
概括
远程监测对于患有炎性肠病 (IBD) 的青少年来说可能是一个安全的替代方案,显示出与标准护理相似的疾病活动控制. 这种方法可能会略微降低医疗保健成本和门诊访问.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 数字健康数字健康
- 炎症性肠病 (IBD) 管理管理
背景情况:
- 在患有炎症性肠病 (IBD) 的成年人中,远程监测已经显示出改善生活质量和降低成本的好处,而不会影响疾病活动.
- 之前在IBD成年人身上进行的研究表明,远程监测可与标准治疗疾病活动和爆发发生情况相提并论.
- 远程监控可以改善生活质量,降低成本,并减少成人IBD患者的医疗保健利用率.
研究的目的:
- 评估远程监测是否与控制IBD青少年疾病活动的标准护理不劣.
- 评估二次结果,包括生活质量,成本,患者满意度,坚持和医疗保健利用率.
主要方法:
- 随机试验的系统审查,将远程监测与IBD青少年的标准护理进行比较.
- 搜索了Medline和Embase数据库,截至2025年6月15日.
- 使用偏差风险2工具评估偏差风险,使用GRADE评估证据确定性.
主要成果:
- 包括三项涉及309名患者的研究,其中一项被评为"高"的偏差风险,两项被评为"一些担忧".
- 远程监测可能不会使IBD青少年的疾病活动恶化 (低确定性证据).
- 与标准护理相比,远程监控几乎没有改善生活质量 (低确定性证据),但可能导致成本略有降低 (中等确定性证据).
结论:
- 远程监测似乎不低于标准护理,用于管理IBD青少年的疾病活动.
- 远程监测对于患有IBD的青少年来说是一个潜在的安全策略,可能会根据有限的证据减少门诊和社会成本.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
01:30Inflammatory Bowel Disease II: Crohn's Disease
383
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
01:29Inflammatory Bowel Disease IV: Pharmacological Management
190
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
190
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
324
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
324
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
303
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
303
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271